“Cell Therapy: An Emerging Drug Class” Biju Parekkadan, PhD Assistant Professor of Surgery Harvard Medical...
Hao Wu, MD PhD
- Boston Medical Center, Boston, MA, U.S.A. (July 2009-present)
- PGY-1, Albany Medical Center, Albany, NY, USA (July 2008- June 2009)
- Graduate School:
- Ph.D. in Pathology, Boston University, Boston, MA, USA (2002-2008)
- Medical School:
- Xi’an Medical University, Xi’an, Shaanxi, China
Anatomic Pathology/Clinical Pathology (AP/CP)
H. Wu, K. Symes, D. C. Seldin and I. Dominguez. Threonine 393 of beta-catenin regulates interaction with Axin. 2009, J Cell Biochem. Vol. 108(1):52-63.
I. Dominguez, J. Mizuno, H. Wu, G.A. Imbrie, K. Symes and D .C. Seldin. A role for CK2/β in Xenopus early embryonic development. 2005, Mol. Cell. Biochemistry. Vol. 274:125-131
I. Dominguez, J. Mizuno, H. Wu, D. Song, K. Symes and D. C. Seldin. Protein kinase CK2 is required for dorsal axis formation in Xenopus embryos. 2004, Dev. Biol., Vol. 274:110-124
M. Qin, Z. Yang, X. Luo, X. Tu, F. Zhou and H. Wu. Establishment of Helicobacter pylori infection mouse model and determination of the optimum infection dosage. 2002, Progress in Microbiology and Immunology, Vol. 30: 18-22
PERSONAL COMMENTS REGARDING THE PROGRAM-
I like the program’s commitment to resident education. The strong research presence and the collaborative working environment make BUMC a very desirable program.